AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Anglo American PLC

Transaction in Own Shares Aug 2, 2019

4786_rns_2019-08-02_82074187-4f06-422b-b30d-1cbca3524dda.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6481H

Anglo American PLC

02 August 2019

Anglo American plc (the "Company")

Registered office: 20 Carlton House Terrace, London SW1Y 5AN

Registered number: 3564138 (incorporated in England and Wales)

Legal Entity Identifier: 549300S9XF92D1X8ME43
Transaction in Own Shares

Anglo American plc announces that it has purchased the following number of its ordinary shares of US$0.54945 each on Exchange (as defined in the Rules of the London Stock Exchange) from Morgan Stanley & Co International plc ("Morgan Stanley") as part of its buyback programme announced on 25 July 2019 (the "Programme").

Date of purchase: 1 August 2019
Number of ordinary shares US$0.54945 each purchased: 540,405
Highest price paid per share (£): £20.1850
Lowest price paid per share (£): £19.1846
Volume weighted average price paid per share (£): £19.5612

Anglo American will cancel the purchased shares.

Full details of the transactions, in aggregated and detailed form, are available at www.angloamerican.com/investors/shareholder-information/share-purchase-transactions.

Ellie Klonarides

Deputy Company Secretary                                                                   

Anglo American plc

2 August 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

POSUAVNRKOAWRAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.